Delayed endophthalmitis in a child following an Ahmed glaucoma valve implant.
Al-Torbaq
Abdullah A
AA
Department of Ophthalmology, Al-Qassim Medical College, King Saud, University, Buraidah, Saudi Arabia.
Edward
Deepak P
DP
D002386:Cataract / Q000151:congenital; D002387:Cataract Extraction / Q000009:adverse effects; D002442:Ceftazidime / Q000008:administration & dosage; D002648:Child; D003907:Dexamethasone / Q000008:administration & dosage; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D009877:Endophthalmitis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D015818:Eye Infections, Bacterial / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D005260:Female; D005901:Glaucoma / Q000209:etiology / Q000601:surgery*; D020327:Glaucoma Drainage Implants / Q000009:adverse effects*; D006192:Haemophilus Infections / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D006193:Haemophilus influenzae / Q000302:isolation & purification*; D006801:Humans; D007429:Intraocular Pressure; D019919:Prosthesis Implantation / Q000009:adverse effects; D014640:Vancomycin / Q000008:administration & dosage; D014821:Vitrectomy; D014822:Vitreous Body / Q000382:microbiology
D014640:Vancomycin; D003907:Dexamethasone; D002442:Ceftazidime